Immunotherapies Show Promise in Small-Cell Lung Cancer
This video reviews immunotherapy trials in small-cell lung cancer, including studies on pembrolizumab, nivolumab monotherapy, and nivolumab in combination with ipilimumab.
Targeted Agent Rova-T Active in Small-Cell Lung Cancer
This video discusses the phase I trial of rovalpituzumab (Rova-T) for the treatment of patients with small-cell lung cancer.
Progress and Pitfalls in Small-Cell Lung Cancer
mall-cell lung cancer (SCLC) is a distinct clinicopathologic entity that is characterized by neuroendocrine differentiation, early metastatic spread, and initial responsiveness to cytotoxic therapy.
By clicking Accept, you agree to become a member of the UBM Medica Community.